Search clinical trials for: Pasireotide (SOM230)
Total 87 results
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Robert R. Henry, MDVeterans Medical Research FoundationCompletedHyperglycemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedPancreatic CancerUnited States
-
Novartis PharmaceuticalsApproved for marketing
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaboratorsCompleted
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedRenal ImpairmentGermany, South Africa
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Montefiore Medical CenterNovartis PharmaceuticalsWithdrawnHyperinsulinism | Insulinoma | Congenital Hyperinsulinism
-
Novartis PharmaceuticalsTerminatedCluster Headache - Episodic and ChronicUnited States, United Kingdom, Germany
-
Novartis PharmaceuticalsCompletedCushing's SyndromeUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedPostoperative Dumping SyndromeBelgium
-
RECORDATI GROUPCompletedCushings DiseaseCanada, France, Germany, Italy, United States, Israel, Romania, Colombia, Lebanon, Netherlands, United Kingdom
-
Cedars-Sinai Medical CenterNovartisWithdrawn
-
Montefiore Medical CenterNo longer availableCongenital HyperinsulinismUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Erasmus Medical CenterNovartisUnknown
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Australia, Belgium, Germany, Switzerland, United States, France
-
University of UtahNovartisTerminated
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Prof. Dr. Berthold SchalkeCrolll GmbhCompletedPrimary Inoperable Thymoma | Local Recurrent ThymomaGermany
-
Novartis PharmaceuticalsCompletedCushing DiseaseUnited States, Italy, France, Germany, United Kingdom
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Germany, Italy, Belgium, Taiwan, Turkey, Switzerland, Israel, Netherlands, Sweden, United Kingdom, Korea, Republic of, Spain, France, Canada, Greece, Russian Federation, Denmark, Mexico, China, Hungary, Norway, Argentina and more
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
-
Emory UniversityNovartisCompletedNeuroendocrine TumorsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
RECORDATI GROUPActive, not recruitingProstate Cancer | Neuroendocrine Tumors | Acromegaly | Cushing's Disease | Dumping Syndrome | Pituitary Tumors | Ectopic ACTH Secreting (EAS) Tumors | Melanoma Negative for bRAF | Melanoma Negative for nRASBelgium, Brazil, Bulgaria, Canada, France, Germany, Italy, Japan, Korea, Republic of, Thailand, Turkey, United States, Argentina, Greece, Hungary, India, Israel, Malaysia, Mexico, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation and more
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
RECORDATI GROUPRecruitingPost-Bariatric HypoglycemiaUnited States, Belgium, France, Italy, Spain, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted